597563-26-3

Downstream Products

• 674311-09-2 tert-butyl (1S,2R)-1-(3,5-difluorobenzyl)-3-{[3-[(dipropylamino)carbonyl]-5-(1,3-oxazol-2-yl)benzoyl]-3-[(trifluoromethyl)benzyl]amino}-2-hydroxypropylcarbamate 
• 674311-07-0 (1R,2S)-2-[(tert-butoxycarbonyl)amino]-1-({(tert-butoxycarbonyl)[3-(trifluoromethyl)benzyl]amino}methyl)-3-(3,5-difluorophenyl)propyl-3-[(dipropylamino)carbonyl]-5-(1,3-oxazol-2-yl)benzoate 
• 910448-07-6 C₄₄H₆₆N₄O₈SSi 
• 910447-98-2 C₄₄H₆₄F₂N₄O₇Si 
• 527716-94-5 N₁-{(1S,2R)-1-(3,5-difluorobenzyl)-3-{[1-(3-ethynylphenyl)cyclopropyl]amino}-2-hydroxypropyl}-5-(1,3-oxazol-2-yl)-N₃,N₃-dipropylisophthalamide 
• 527716-71-8 N₁-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-5-(1,3-oxazol-2-yl)-N₃,N₃-dipropylisophthalamide 

Relevant academic research and scientific papers

1,3-DIAMINO-2-HYDROXYPROPANE PRODRUG DERIVATIVES

The present invention relates to compounds of formula (AA), (I) and (X), useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's dis

PROCESS FOR PREPARING 5-(1, 3-OXAZOL-2-YL) BENZOIC ACID DERIVATIVES

Disclosed are compounds of formula III and a process to prepare a compound of formula III wherein R1, R2, R3 and R6 are defined herein, using a zinc chloride/optionally substituted oxazole adduct and an compound